Name: Pharmaceutical Crystals (Volume II) (en Inglés)
SKU: 54770670
Price: 69.13 USD
Availability: InStock
Author: Yonemochi, Etsuo ; Uekusa, Hidehiro

portada Pharmaceutical Crystals (Volume II) (en Inglés)

Pharmaceutical Crystals (Volume II) (en Inglés)

Formato

Libro Físico

Editorial

Mdpi AG

Autor

Yonemochi, Etsuo ; Uekusa, Hidehiro

Idioma

Inglés

N° páginas

176

Encuadernación

Tapa Dura

Dimensiones

24.4x17x1.6 cm

Peso

0.58 kg.

ISBN13

9783036554730

Categorías

Farmacología

Pharmaceutical Crystals (Volume II) (en Inglés)

Yonemochi, Etsuo ; Uekusa, Hidehiro (Autor) · Mdpi AG · Tapa Dura

Libro Nuevo Importado

Envío: 21 a 28 días háb.

$ 138.26$ 69.13

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 69.13

Llega entre el 25 Sep y el 08 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Pharmaceutical Crystals (Volume II) (en Inglés)"

The crystalline state is the most commonly used as an essential solid in active pharmaceutical ingredients (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines. Still, the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. These properties should be understood in terms of molecular structures and interactions between molecules in crystals. Information on three-dimensional molecular structures also affords insights into the biological activity of molecules.The second reprint in the series, "Crystalline Pharmaceuticals (Volume II)" focused on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts and hydrates, and polymorph crystals, were reported with interest. Such crystal structures contributed to the latest studies that combine morphology, spectroscopic, theoretical calculation, and thermal analysis with the crystallographic study. Thus, this reprint highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure-property study of pharmaceutical crystals. The Guest Editors of this reprint hope the readers enjoy a wide variety of recent studies on "Crystalline Pharmaceuticals."